ACE to ARB
Aug 28, 2013•22 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Should we screen for prostate cancer? A study published on bmj.com suggests that it doesn’t improve survival rates, and could lead to over treatment. Gabriel Sandblom, of the Karolinska Institute, tells us about his research.
Also, James Ritter, emeritus professor of pharmacology at King’s College London, explains the As in the ABCD of hypertension treatment.
For the best experience, listen in Metacast app for iOS or Android